サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1386693

世界の生体分子ソフトウェア市場：考察と予測 (2029年まで)

Global Biomolecule Software Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 127 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の生体分子ソフトウェア市場：考察と予測 (2029年まで)
出版日: 2023年11月29日
発行: QYResearch
ページ情報: 英文 127 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、生体分子ソフトウェア (Biomolecule Software) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の生体分子ソフトウェアの市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Windows
    • Linux
    • MacOS
  • 市場：用途別
    • 世界の生体分子ソフトウェアの市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Hospital
    • Clinic
    • Research Center
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の生体分子ソフトウェアの市場展望 (2018-2029)
  • 世界の生体分子ソフトウェアの市場成長トレンド：地域別
    • 生体分子ソフトウェア 市場規模：地域別: 2018 VS 2022 VS 2029
    • 生体分子ソフトウェアの市場規模実績：地域別 (2018-2023)
    • 生体分子ソフトウェアの市場規模予測：地域別 (2024-2029)
  • 生体分子ソフトウェア 市場動向
    • 生体分子ソフトウェア 業界動向
    • 生体分子ソフトウェア 市場の促進要因
    • 生体分子ソフトウェア 市場の課題
    • 生体分子ソフトウェア 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 生体分子ソフトウェア ：競合別
    • 世界の生体分子ソフトウェアの収益：企業別 (2018-2023)
    • 世界の生体分子ソフトウェアの収益シェア：企業別 (2018-2023)
  • 世界の生体分子ソフトウェアの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 生体分子ソフトウェア, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界の生体分子ソフトウェア 市場集中度
    • 世界の生体分子ソフトウェア 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 生体分子ソフトウェアの収益 2022
  • 世界の主要企業 生体分子ソフトウェア 本社 および提供地域
  • 世界の主要企業 生体分子ソフトウェア, 製品およびアプリケーション
  • 世界の主要企業 生体分子ソフトウェア, 業界参入時期
  • M&A, 拡張計画

第4章 生体分子ソフトウェア 内訳データ：タイプ別

  • 世界の生体分子ソフトウェアの市場規模実績：タイプ別 (2018-2023)
  • 世界の生体分子ソフトウェアの市場規模予測：タイプ別 (2024-2029)

第5章 生体分子ソフトウェア 内訳データ：用途別

  • 世界の生体分子ソフトウェアの市場規模実績：用途別 (2018-2023)
  • 世界の生体分子ソフトウェアの市場規模予測：用途別 (2024-2029)

第6章 北米

  • 北米の生体分子ソフトウェア 市場規模 (2018-2029)
  • 北米の生体分子ソフトウェア 市場規模：タイプ別
    • 北米の生体分子ソフトウェア 市場規模：タイプ別 (2018-2023)
    • 北米の生体分子ソフトウェア 市場規模：タイプ別 (2024-2029)
    • 北米の生体分子ソフトウェアの市場シェア：タイプ別 (2018-2029)
  • 北米の生体分子ソフトウェア 市場規模：用途別
    • 北米の生体分子ソフトウェア 市場規模：用途別 (2018-2023)
    • 北米の生体分子ソフトウェア 市場規模：用途別 (2024-2029)
    • 北米の生体分子ソフトウェアの市場シェア：用途別 (2018-2029)
  • 北米の生体分子ソフトウェア 市場規模：国別
    • 北米の生体分子ソフトウェア 市場規模：国別: 2018 VS 2022 VS 2029
    • 北米の生体分子ソフトウェア 市場規模：国別 (2018-2023)
    • 北米の生体分子ソフトウェア 市場規模：国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の生体分子ソフトウェア 市場規模 (2018-2029)
  • 欧州の生体分子ソフトウェア 市場規模：タイプ別
    • 欧州の生体分子ソフトウェア 市場規模：タイプ別 (2018-2023)
    • 欧州の生体分子ソフトウェア 市場規模：タイプ別 (2024-2029)
    • 欧州の生体分子ソフトウェアの市場シェア：タイプ別 (2018-2029)
  • 欧州の生体分子ソフトウェア 市場規模：用途別
    • 欧州の生体分子ソフトウェア 市場規模：用途別 (2018-2023)
    • 欧州の生体分子ソフトウェア 市場規模：用途別 (2024-2029)
    • 欧州の生体分子ソフトウェアの市場シェア：用途別 (2018-2029)
  • 欧州の生体分子ソフトウェア 市場規模：国別
    • 欧州の生体分子ソフトウェア 市場規模：国別: 2018 VS 2022 VS 2029
    • 欧州の生体分子ソフトウェア 市場規模：国別 (2018-2023)
    • 欧州の生体分子ソフトウェア 市場規模：国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の生体分子ソフトウェア 市場規模 (2018-2029)
  • 中国の生体分子ソフトウェア 市場規模：タイプ別
    • 中国の生体分子ソフトウェア 市場規模：タイプ別 (2018-2023)
    • 中国の生体分子ソフトウェア 市場規模：タイプ別 (2024-2029)
    • 中国の生体分子ソフトウェアの市場シェア：タイプ別 (2018-2029)
  • 中国の生体分子ソフトウェア 市場規模：用途別
    • 中国の生体分子ソフトウェア 市場規模：用途別 (2018-2023)
    • 中国の生体分子ソフトウェア 市場規模：用途別 (2024-2029)
    • 中国の生体分子ソフトウェアの市場シェア：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 生体分子ソフトウェア 市場規模 (2018-2029)
  • アジア地域 生体分子ソフトウェア 市場規模：タイプ別
    • アジア地域 生体分子ソフトウェア 市場規模：タイプ別 (2018-2023)
    • アジア地域 生体分子ソフトウェア 市場規模：タイプ別 (2024-2029)
    • アジア地域 生体分子ソフトウェアの市場シェア：タイプ別 (2018-2029)
  • アジア地域 生体分子ソフトウェア 市場規模：用途別
    • アジア地域 生体分子ソフトウェア 市場規模：用途別 (2018-2023)
    • アジア地域 生体分子ソフトウェア 市場規模：用途別 (2024-2029)
    • アジア地域 生体分子ソフトウェアの市場シェア：用途別 (2018-2029)
  • アジア地域 生体分子ソフトウェア 市場規模：地域別
    • アジア地域 生体分子ソフトウェア 市場規模：地域別: 2018 VS 2022 VS 2029
    • アジア地域 生体分子ソフトウェア 市場規模：地域別 (2018-2023)
    • アジア地域 生体分子ソフトウェア 市場規模：地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 生体分子ソフトウェア 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 生体分子ソフトウェア 市場規模：タイプ別
    • 中近東・アフリカ・中南米 生体分子ソフトウェア 市場規模：タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 生体分子ソフトウェア 市場規模：タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 生体分子ソフトウェアの市場シェア：タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 生体分子ソフトウェア 市場規模：用途別
    • 中近東・アフリカ・中南米 生体分子ソフトウェア 市場規模：用途別 (2018-2023)
    • 中近東・アフリカ・中南米 生体分子ソフトウェア 市場規模：用途別 (2024-2029)
    • 中近東・アフリカ・中南米 生体分子ソフトウェアの市場シェア：用途別 (2018-2029)
  • 中近東・アフリカ・中南米 生体分子ソフトウェア 市場規模：国別
    • 中近東・アフリカ・中南米 生体分子ソフトウェア 市場規模：国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 生体分子ソフトウェア 市場規模：国別 (2018-2023)
    • 中近東・アフリカ・中南米 生体分子ソフトウェア 市場規模：国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Hamilton Thorne
  • Hermes Medical Solutions, Inc
  • INDICAL BIOSCIENCE
  • lexogen
  • Repligen
  • SCC SOFT COMPUTER
  • Oxford Instruments
  • Partek, Inc.
  • Stilla Technologies
  • Vela Diagnostics
  • Vittoriobasurto
  • SCIEX
  • SoftGenetics, LLC.
  • Benchling
  • BioSistemika
  • CapitalBio Technology
  • cytena GmbH
  • Eppendorf SE
  • GenomSys
  • Mission Bio
  • Multid Analyses AB
  • PhenoSystems SA
  • Progenie Molecular

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Biomolecule Software Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Windows
  • Table 3. Key Players of Linux
  • Table 4. Key Players of MacOS
  • Table 5. Global Biomolecule Software Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 6. Global Biomolecule Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global Biomolecule Software Market Size by Region (2018-2023) & (US$ Million)
  • Table 8. Global Biomolecule Software Market Share by Region (2018-2023)
  • Table 9. Global Biomolecule Software Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 10. Global Biomolecule Software Market Share by Region (2024-2029)
  • Table 11. Biomolecule Software Market Trends
  • Table 12. Biomolecule Software Market Drivers
  • Table 13. Biomolecule Software Market Challenges
  • Table 14. Biomolecule Software Market Restraints
  • Table 15. Global Biomolecule Software Revenue by Players (2018-2023) & (US$ Million)
  • Table 16. Global Biomolecule Software Revenue Share by Players (2018-2023)
  • Table 17. Global Top Biomolecule Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomolecule Software as of 2022)
  • Table 18. Global Biomolecule Software Industry Ranking 2021 VS 2022 VS 2023
  • Table 19. Global 5 Largest Players Market Share by Biomolecule Software Revenue (CR5 and HHI) & (2018-2023)
  • Table 20. Global Key Players of Biomolecule Software, Headquarters and Area Served
  • Table 21. Global Key Players of Biomolecule Software, Product and Application
  • Table 22. Global Key Players of Biomolecule Software, Product and Application
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Biomolecule Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 25. Global Biomolecule Software Revenue Market Share by Type (2018-2023)
  • Table 26. Global Biomolecule Software Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 27. Global Biomolecule Software Revenue Market Share by Type (2024-2029)
  • Table 28. Global Biomolecule Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 29. Global Biomolecule Software Revenue Share by Application (2018-2023)
  • Table 30. Global Biomolecule Software Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 31. Global Biomolecule Software Revenue Share by Application (2024-2029)
  • Table 32. North America Biomolecule Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 33. North America Biomolecule Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 34. North America Biomolecule Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 35. North America Biomolecule Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 36. North America Biomolecule Software Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. North America Biomolecule Software Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. North America Biomolecule Software Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Europe Biomolecule Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 40. Europe Biomolecule Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 41. Europe Biomolecule Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 42. Europe Biomolecule Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 43. Europe Biomolecule Software Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 44. Europe Biomolecule Software Market Size by Country (2018-2023) & (US$ Million)
  • Table 45. Europe Biomolecule Software Market Size by Country (2024-2029) & (US$ Million)
  • Table 46. China Biomolecule Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 47. China Biomolecule Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 48. China Biomolecule Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 49. China Biomolecule Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 50. Asia Biomolecule Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 51. Asia Biomolecule Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 52. Asia Biomolecule Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 53. Asia Biomolecule Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 54. Asia Biomolecule Software Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 55. Asia Biomolecule Software Market Size by Region (2018-2023) & (US$ Million)
  • Table 56. Asia Biomolecule Software Market Size by Region (2024-2029) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Biomolecule Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Biomolecule Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Biomolecule Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Biomolecule Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America Biomolecule Software Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 62. Middle East, Africa, and Latin America Biomolecule Software Market Size by Country (2018-2023) & (US$ Million)
  • Table 63. Middle East, Africa, and Latin America Biomolecule Software Market Size by Country (2024-2029) & (US$ Million)
  • Table 64. Hamilton Thorne Company Details
  • Table 65. Hamilton Thorne Business Overview
  • Table 66. Hamilton Thorne Biomolecule Software Product
  • Table 67. Hamilton Thorne Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 68. Hamilton Thorne Recent Developments
  • Table 69. Hermes Medical Solutions, Inc Company Details
  • Table 70. Hermes Medical Solutions, Inc Business Overview
  • Table 71. Hermes Medical Solutions, Inc Biomolecule Software Product
  • Table 72. Hermes Medical Solutions, Inc Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 73. Hermes Medical Solutions, Inc Recent Developments
  • Table 74. INDICAL BIOSCIENCE Company Details
  • Table 75. INDICAL BIOSCIENCE Business Overview
  • Table 76. INDICAL BIOSCIENCE Biomolecule Software Product
  • Table 77. INDICAL BIOSCIENCE Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 78. INDICAL BIOSCIENCE Recent Developments
  • Table 79. lexogen Company Details
  • Table 80. lexogen Business Overview
  • Table 81. lexogen Biomolecule Software Product
  • Table 82. lexogen Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 83. lexogen Recent Developments
  • Table 84. Repligen Company Details
  • Table 85. Repligen Business Overview
  • Table 86. Repligen Biomolecule Software Product
  • Table 87. Repligen Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 88. Repligen Recent Developments
  • Table 89. SCC SOFT COMPUTER Company Details
  • Table 90. SCC SOFT COMPUTER Business Overview
  • Table 91. SCC SOFT COMPUTER Biomolecule Software Product
  • Table 92. SCC SOFT COMPUTER Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 93. SCC SOFT COMPUTER Recent Developments
  • Table 94. Oxford Instruments Company Details
  • Table 95. Oxford Instruments Business Overview
  • Table 96. Oxford Instruments Biomolecule Software Product
  • Table 97. Oxford Instruments Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 98. Oxford Instruments Recent Developments
  • Table 99. Partek, Inc. Company Details
  • Table 100. Partek, Inc. Business Overview
  • Table 101. Partek, Inc. Biomolecule Software Product
  • Table 102. Partek, Inc. Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 103. Partek, Inc. Recent Developments
  • Table 104. Stilla Technologies Company Details
  • Table 105. Stilla Technologies Business Overview
  • Table 106. Stilla Technologies Biomolecule Software Product
  • Table 107. Stilla Technologies Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 108. Stilla Technologies Recent Developments
  • Table 109. Vela Diagnostics Company Details
  • Table 110. Vela Diagnostics Business Overview
  • Table 111. Vela Diagnostics Biomolecule Software Product
  • Table 112. Vela Diagnostics Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 113. Vela Diagnostics Recent Developments
  • Table 114. Vittoriobasurto Company Details
  • Table 115. Vittoriobasurto Business Overview
  • Table 116. Vittoriobasurto Biomolecule Software Product
  • Table 117. Vittoriobasurto Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 118. Vittoriobasurto Recent Developments
  • Table 119. SCIEX Company Details
  • Table 120. SCIEX Business Overview
  • Table 121. SCIEX Biomolecule Software Product
  • Table 122. SCIEX Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 123. SCIEX Recent Developments
  • Table 124. SoftGenetics, LLC. Company Details
  • Table 125. SoftGenetics, LLC. Business Overview
  • Table 126. SoftGenetics, LLC. Biomolecule Software Product
  • Table 127. SoftGenetics, LLC. Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 128. SoftGenetics, LLC. Recent Developments
  • Table 129. Benchling Company Details
  • Table 130. Benchling Business Overview
  • Table 131. Benchling Biomolecule Software Product
  • Table 132. Benchling Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 133. Benchling Recent Developments
  • Table 134. BioSistemika Company Details
  • Table 135. BioSistemika Business Overview
  • Table 136. BioSistemika Biomolecule Software Product
  • Table 137. BioSistemika Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 138. BioSistemika Recent Developments
  • Table 139. CapitalBio Technology Company Details
  • Table 140. CapitalBio Technology Business Overview
  • Table 141. CapitalBio Technology Biomolecule Software Product
  • Table 142. CapitalBio Technology Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 143. CapitalBio Technology Recent Developments
  • Table 144. cytena GmbH Company Details
  • Table 145. cytena GmbH Business Overview
  • Table 146. cytena GmbH Biomolecule Software Product
  • Table 147. cytena GmbH Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 148. cytena GmbH Recent Developments
  • Table 149. Eppendorf SE Company Details
  • Table 150. Eppendorf SE Business Overview
  • Table 151. Eppendorf SE Biomolecule Software Product
  • Table 152. Eppendorf SE Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 153. Eppendorf SE Recent Developments
  • Table 154. GenomSys Company Details
  • Table 155. GenomSys Business Overview
  • Table 156. GenomSys Biomolecule Software Product
  • Table 157. GenomSys Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 158. GenomSys Recent Developments
  • Table 159. Mission Bio Company Details
  • Table 160. Mission Bio Business Overview
  • Table 161. Mission Bio Biomolecule Software Product
  • Table 162. Mission Bio Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 163. Mission Bio Recent Developments
  • Table 164. Multid Analyses AB Company Details
  • Table 165. Multid Analyses AB Business Overview
  • Table 166. Multid Analyses AB Biomolecule Software Product
  • Table 167. Multid Analyses AB Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 168. Multid Analyses AB Recent Developments
  • Table 169. PhenoSystems SA Company Details
  • Table 170. PhenoSystems SA Business Overview
  • Table 171. PhenoSystems SA Biomolecule Software Product
  • Table 172. PhenoSystems SA Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 173. PhenoSystems SA Recent Developments
  • Table 174. Progenie Molecular Company Details
  • Table 175. Progenie Molecular Business Overview
  • Table 176. Progenie Molecular Biomolecule Software Product
  • Table 177. Progenie Molecular Revenue in Biomolecule Software Business (2018-2023) & (US$ Million)
  • Table 178. Progenie Molecular Recent Developments
  • Table 179. Research Programs/Design for This Report
  • Table 180. Key Data Information from Secondary Sources
  • Table 181. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Biomolecule Software Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Biomolecule Software Market Share by Type: 2022 VS 2029
  • Figure 3. Windows Features
  • Figure 4. Linux Features
  • Figure 5. MacOS Features
  • Figure 6. Global Biomolecule Software Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Biomolecule Software Market Share by Application: 2022 VS 2029
  • Figure 8. Hospital Case Studies
  • Figure 9. Clinic Case Studies
  • Figure 10. Research Center Case Studies
  • Figure 11. Biomolecule Software Report Years Considered
  • Figure 12. Global Biomolecule Software Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 13. Global Biomolecule Software Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 14. Global Biomolecule Software Market Share by Region: 2022 VS 2029
  • Figure 15. Global Biomolecule Software Market Share by Players in 2022
  • Figure 16. Global Top Biomolecule Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomolecule Software as of 2022)
  • Figure 17. The Top 10 and 5 Players Market Share by Biomolecule Software Revenue in 2022
  • Figure 18. North America Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 19. North America Biomolecule Software Market Share by Type (2018-2029)
  • Figure 20. North America Biomolecule Software Market Share by Application (2018-2029)
  • Figure 21. North America Biomolecule Software Market Share by Country (2018-2029)
  • Figure 22. United States Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. Canada Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. Europe Biomolecule Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 25. Europe Biomolecule Software Market Share by Type (2018-2029)
  • Figure 26. Europe Biomolecule Software Market Share by Application (2018-2029)
  • Figure 27. Europe Biomolecule Software Market Share by Country (2018-2029)
  • Figure 28. Germany Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. France Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. U.K. Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Italy Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Russia Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. Nordic Countries Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. China Biomolecule Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 35. China Biomolecule Software Market Share by Type (2018-2029)
  • Figure 36. China Biomolecule Software Market Share by Application (2018-2029)
  • Figure 37. Asia Biomolecule Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 38. Asia Biomolecule Software Market Share by Type (2018-2029)
  • Figure 39. Asia Biomolecule Software Market Share by Application (2018-2029)
  • Figure 40. Asia Biomolecule Software Market Share by Region (2018-2029)
  • Figure 41. Japan Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. South Korea Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. China Taiwan Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. Southeast Asia Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. India Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Australia Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. Middle East, Africa, and Latin America Biomolecule Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 48. Middle East, Africa, and Latin America Biomolecule Software Market Share by Type (2018-2029)
  • Figure 49. Middle East, Africa, and Latin America Biomolecule Software Market Share by Application (2018-2029)
  • Figure 50. Middle East, Africa, and Latin America Biomolecule Software Market Share by Country (2018-2029)
  • Figure 51. Brazil Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 52. Mexico Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Turkey Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Saudi Arabia Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Israel Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. GCC Countries Biomolecule Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. Hamilton Thorne Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 58. Hermes Medical Solutions, Inc Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 59. INDICAL BIOSCIENCE Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 60. lexogen Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 61. Repligen Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 62. SCC SOFT COMPUTER Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 63. Oxford Instruments Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 64. Partek, Inc. Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 65. Stilla Technologies Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 66. Vela Diagnostics Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 67. Vittoriobasurto Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 68. SCIEX Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 69. SoftGenetics, LLC. Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 70. Benchling Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 71. BioSistemika Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 72. CapitalBio Technology Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 73. cytena GmbH Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 74. Eppendorf SE Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 75. GenomSys Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 76. Mission Bio Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 77. Multid Analyses AB Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 78. PhenoSystems SA Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 79. Progenie Molecular Revenue Growth Rate in Biomolecule Software Business (2018-2023)
  • Figure 80. Bottom-up and Top-down Approaches for This Report
  • Figure 81. Data Triangulation
  • Figure 82. Key Executives Interviewed
目次

This research report focuses on the Biomolecule Software Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Biomolecule Software Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Windows
    • 1.2.3 Linux
    • 1.2.4 MacOS
  • 1.3 Market by Application
    • 1.3.1 Global Biomolecule Software Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Research Center
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Biomolecule Software Market Perspective (2018-2029)
  • 2.2 Global Biomolecule Software Growth Trends by Region
    • 2.2.1 Biomolecule Software Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Biomolecule Software Historic Market Size by Region (2018-2023)
    • 2.2.3 Biomolecule Software Forecasted Market Size by Region (2024-2029)
  • 2.3 Biomolecule Software Market Dynamics
    • 2.3.1 Biomolecule Software Industry Trends
    • 2.3.2 Biomolecule Software Market Drivers
    • 2.3.3 Biomolecule Software Market Challenges
    • 2.3.4 Biomolecule Software Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Biomolecule Software by Players
    • 3.1.1 Global Biomolecule Software Revenue by Players (2018-2023)
    • 3.1.2 Global Biomolecule Software Revenue Market Share by Players (2018-2023)
  • 3.2 Global Biomolecule Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Biomolecule Software, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Biomolecule Software Market Concentration Ratio
    • 3.4.1 Global Biomolecule Software Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Biomolecule Software Revenue in 2022
  • 3.5 Global Key Players of Biomolecule Software Head office and Area Served
  • 3.6 Global Key Players of Biomolecule Software, Product and Application
  • 3.7 Global Key Players of Biomolecule Software, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Biomolecule Software Breakdown Data by Type

  • 4.1 Global Biomolecule Software Historic Market Size by Type (2018-2023)
  • 4.2 Global Biomolecule Software Forecasted Market Size by Type (2024-2029)

5 Biomolecule Software Breakdown Data by Application

  • 5.1 Global Biomolecule Software Historic Market Size by Application (2018-2023)
  • 5.2 Global Biomolecule Software Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Biomolecule Software Market Size (2018-2029)
  • 6.2 North America Biomolecule Software Market Size by Type
    • 6.2.1 North America Biomolecule Software Market Size by Type (2018-2023)
    • 6.2.2 North America Biomolecule Software Market Size by Type (2024-2029)
    • 6.2.3 North America Biomolecule Software Market Share by Type (2018-2029)
  • 6.3 North America Biomolecule Software Market Size by Application
    • 6.3.1 North America Biomolecule Software Market Size by Application (2018-2023)
    • 6.3.2 North America Biomolecule Software Market Size by Application (2024-2029)
    • 6.3.3 North America Biomolecule Software Market Share by Application (2018-2029)
  • 6.4 North America Biomolecule Software Market Size by Country
    • 6.4.1 North America Biomolecule Software Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Biomolecule Software Market Size by Country (2018-2023)
    • 6.4.3 North America Biomolecule Software Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Biomolecule Software Market Size (2018-2029)
  • 7.2 Europe Biomolecule Software Market Size by Type
    • 7.2.1 Europe Biomolecule Software Market Size by Type (2018-2023)
    • 7.2.2 Europe Biomolecule Software Market Size by Type (2024-2029)
    • 7.2.3 Europe Biomolecule Software Market Share by Type (2018-2029)
  • 7.3 Europe Biomolecule Software Market Size by Application
    • 7.3.1 Europe Biomolecule Software Market Size by Application (2018-2023)
    • 7.3.2 Europe Biomolecule Software Market Size by Application (2024-2029)
    • 7.3.3 Europe Biomolecule Software Market Share by Application (2018-2029)
  • 7.4 Europe Biomolecule Software Market Size by Country
    • 7.4.1 Europe Biomolecule Software Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Biomolecule Software Market Size by Country (2018-2023)
    • 7.4.3 Europe Biomolecule Software Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Biomolecule Software Market Size (2018-2029)
  • 8.2 China Biomolecule Software Market Size by Type
    • 8.2.1 China Biomolecule Software Market Size by Type (2018-2023)
    • 8.2.2 China Biomolecule Software Market Size by Type (2024-2029)
    • 8.2.3 China Biomolecule Software Market Share by Type (2018-2029)
  • 8.3 China Biomolecule Software Market Size by Application
    • 8.3.1 China Biomolecule Software Market Size by Application (2018-2023)
    • 8.3.2 China Biomolecule Software Market Size by Application (2024-2029)
    • 8.3.3 China Biomolecule Software Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Biomolecule Software Market Size (2018-2029)
  • 9.2 Asia Biomolecule Software Market Size by Type
    • 9.2.1 Asia Biomolecule Software Market Size by Type (2018-2023)
    • 9.2.2 Asia Biomolecule Software Market Size by Type (2024-2029)
    • 9.2.3 Asia Biomolecule Software Market Share by Type (2018-2029)
  • 9.3 Asia Biomolecule Software Market Size by Application
    • 9.3.1 Asia Biomolecule Software Market Size by Application (2018-2023)
    • 9.3.2 Asia Biomolecule Software Market Size by Application (2024-2029)
    • 9.3.3 Asia Biomolecule Software Market Share by Application (2018-2029)
  • 9.4 Asia Biomolecule Software Market Size by Region
    • 9.4.1 Asia Biomolecule Software Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Biomolecule Software Market Size by Region (2018-2023)
    • 9.4.3 Asia Biomolecule Software Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Biomolecule Software Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Biomolecule Software Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Biomolecule Software Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Biomolecule Software Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Biomolecule Software Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Biomolecule Software Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Biomolecule Software Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Biomolecule Software Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Biomolecule Software Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Biomolecule Software Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Biomolecule Software Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Biomolecule Software Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Biomolecule Software Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Hamilton Thorne
    • 11.1.1 Hamilton Thorne Company Details
    • 11.1.2 Hamilton Thorne Business Overview
    • 11.1.3 Hamilton Thorne Biomolecule Software Introduction
    • 11.1.4 Hamilton Thorne Revenue in Biomolecule Software Business (2018-2023)
    • 11.1.5 Hamilton Thorne Recent Developments
  • 11.2 Hermes Medical Solutions, Inc
    • 11.2.1 Hermes Medical Solutions, Inc Company Details
    • 11.2.2 Hermes Medical Solutions, Inc Business Overview
    • 11.2.3 Hermes Medical Solutions, Inc Biomolecule Software Introduction
    • 11.2.4 Hermes Medical Solutions, Inc Revenue in Biomolecule Software Business (2018-2023)
    • 11.2.5 Hermes Medical Solutions, Inc Recent Developments
  • 11.3 INDICAL BIOSCIENCE
    • 11.3.1 INDICAL BIOSCIENCE Company Details
    • 11.3.2 INDICAL BIOSCIENCE Business Overview
    • 11.3.3 INDICAL BIOSCIENCE Biomolecule Software Introduction
    • 11.3.4 INDICAL BIOSCIENCE Revenue in Biomolecule Software Business (2018-2023)
    • 11.3.5 INDICAL BIOSCIENCE Recent Developments
  • 11.4 lexogen
    • 11.4.1 lexogen Company Details
    • 11.4.2 lexogen Business Overview
    • 11.4.3 lexogen Biomolecule Software Introduction
    • 11.4.4 lexogen Revenue in Biomolecule Software Business (2018-2023)
    • 11.4.5 lexogen Recent Developments
  • 11.5 Repligen
    • 11.5.1 Repligen Company Details
    • 11.5.2 Repligen Business Overview
    • 11.5.3 Repligen Biomolecule Software Introduction
    • 11.5.4 Repligen Revenue in Biomolecule Software Business (2018-2023)
    • 11.5.5 Repligen Recent Developments
  • 11.6 SCC SOFT COMPUTER
    • 11.6.1 SCC SOFT COMPUTER Company Details
    • 11.6.2 SCC SOFT COMPUTER Business Overview
    • 11.6.3 SCC SOFT COMPUTER Biomolecule Software Introduction
    • 11.6.4 SCC SOFT COMPUTER Revenue in Biomolecule Software Business (2018-2023)
    • 11.6.5 SCC SOFT COMPUTER Recent Developments
  • 11.7 Oxford Instruments
    • 11.7.1 Oxford Instruments Company Details
    • 11.7.2 Oxford Instruments Business Overview
    • 11.7.3 Oxford Instruments Biomolecule Software Introduction
    • 11.7.4 Oxford Instruments Revenue in Biomolecule Software Business (2018-2023)
    • 11.7.5 Oxford Instruments Recent Developments
  • 11.8 Partek, Inc.
    • 11.8.1 Partek, Inc. Company Details
    • 11.8.2 Partek, Inc. Business Overview
    • 11.8.3 Partek, Inc. Biomolecule Software Introduction
    • 11.8.4 Partek, Inc. Revenue in Biomolecule Software Business (2018-2023)
    • 11.8.5 Partek, Inc. Recent Developments
  • 11.9 Stilla Technologies
    • 11.9.1 Stilla Technologies Company Details
    • 11.9.2 Stilla Technologies Business Overview
    • 11.9.3 Stilla Technologies Biomolecule Software Introduction
    • 11.9.4 Stilla Technologies Revenue in Biomolecule Software Business (2018-2023)
    • 11.9.5 Stilla Technologies Recent Developments
  • 11.10 Vela Diagnostics
    • 11.10.1 Vela Diagnostics Company Details
    • 11.10.2 Vela Diagnostics Business Overview
    • 11.10.3 Vela Diagnostics Biomolecule Software Introduction
    • 11.10.4 Vela Diagnostics Revenue in Biomolecule Software Business (2018-2023)
    • 11.10.5 Vela Diagnostics Recent Developments
  • 11.11 Vittoriobasurto
    • 11.11.1 Vittoriobasurto Company Details
    • 11.11.2 Vittoriobasurto Business Overview
    • 11.11.3 Vittoriobasurto Biomolecule Software Introduction
    • 11.11.4 Vittoriobasurto Revenue in Biomolecule Software Business (2018-2023)
    • 11.11.5 Vittoriobasurto Recent Developments
  • 11.12 SCIEX
    • 11.12.1 SCIEX Company Details
    • 11.12.2 SCIEX Business Overview
    • 11.12.3 SCIEX Biomolecule Software Introduction
    • 11.12.4 SCIEX Revenue in Biomolecule Software Business (2018-2023)
    • 11.12.5 SCIEX Recent Developments
  • 11.13 SoftGenetics, LLC.
    • 11.13.1 SoftGenetics, LLC. Company Details
    • 11.13.2 SoftGenetics, LLC. Business Overview
    • 11.13.3 SoftGenetics, LLC. Biomolecule Software Introduction
    • 11.13.4 SoftGenetics, LLC. Revenue in Biomolecule Software Business (2018-2023)
    • 11.13.5 SoftGenetics, LLC. Recent Developments
  • 11.14 Benchling
    • 11.14.1 Benchling Company Details
    • 11.14.2 Benchling Business Overview
    • 11.14.3 Benchling Biomolecule Software Introduction
    • 11.14.4 Benchling Revenue in Biomolecule Software Business (2018-2023)
    • 11.14.5 Benchling Recent Developments
  • 11.15 BioSistemika
    • 11.15.1 BioSistemika Company Details
    • 11.15.2 BioSistemika Business Overview
    • 11.15.3 BioSistemika Biomolecule Software Introduction
    • 11.15.4 BioSistemika Revenue in Biomolecule Software Business (2018-2023)
    • 11.15.5 BioSistemika Recent Developments
  • 11.16 CapitalBio Technology
    • 11.16.1 CapitalBio Technology Company Details
    • 11.16.2 CapitalBio Technology Business Overview
    • 11.16.3 CapitalBio Technology Biomolecule Software Introduction
    • 11.16.4 CapitalBio Technology Revenue in Biomolecule Software Business (2018-2023)
    • 11.16.5 CapitalBio Technology Recent Developments
  • 11.17 cytena GmbH
    • 11.17.1 cytena GmbH Company Details
    • 11.17.2 cytena GmbH Business Overview
    • 11.17.3 cytena GmbH Biomolecule Software Introduction
    • 11.17.4 cytena GmbH Revenue in Biomolecule Software Business (2018-2023)
    • 11.17.5 cytena GmbH Recent Developments
  • 11.18 Eppendorf SE
    • 11.18.1 Eppendorf SE Company Details
    • 11.18.2 Eppendorf SE Business Overview
    • 11.18.3 Eppendorf SE Biomolecule Software Introduction
    • 11.18.4 Eppendorf SE Revenue in Biomolecule Software Business (2018-2023)
    • 11.18.5 Eppendorf SE Recent Developments
  • 11.19 GenomSys
    • 11.19.1 GenomSys Company Details
    • 11.19.2 GenomSys Business Overview
    • 11.19.3 GenomSys Biomolecule Software Introduction
    • 11.19.4 GenomSys Revenue in Biomolecule Software Business (2018-2023)
    • 11.19.5 GenomSys Recent Developments
  • 11.20 Mission Bio
    • 11.20.1 Mission Bio Company Details
    • 11.20.2 Mission Bio Business Overview
    • 11.20.3 Mission Bio Biomolecule Software Introduction
    • 11.20.4 Mission Bio Revenue in Biomolecule Software Business (2018-2023)
    • 11.20.5 Mission Bio Recent Developments
  • 11.21 Multid Analyses AB
    • 11.21.1 Multid Analyses AB Company Details
    • 11.21.2 Multid Analyses AB Business Overview
    • 11.21.3 Multid Analyses AB Biomolecule Software Introduction
    • 11.21.4 Multid Analyses AB Revenue in Biomolecule Software Business (2018-2023)
    • 11.21.5 Multid Analyses AB Recent Developments
  • 11.22 PhenoSystems SA
    • 11.22.1 PhenoSystems SA Company Details
    • 11.22.2 PhenoSystems SA Business Overview
    • 11.22.3 PhenoSystems SA Biomolecule Software Introduction
    • 11.22.4 PhenoSystems SA Revenue in Biomolecule Software Business (2018-2023)
    • 11.22.5 PhenoSystems SA Recent Developments
  • 11.23 Progenie Molecular
    • 11.23.1 Progenie Molecular Company Details
    • 11.23.2 Progenie Molecular Business Overview
    • 11.23.3 Progenie Molecular Biomolecule Software Introduction
    • 11.23.4 Progenie Molecular Revenue in Biomolecule Software Business (2018-2023)
    • 11.23.5 Progenie Molecular Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details